NY State employers no longer allowed to test for cannabis use, Luxembourg to legalize personal cannabis growth, and Curaleaf the target of lawsuits over mislabeled cannabinoid tinctures in Idaho.
There can be a lot to keep track of when it comes to the fast-paced world of cannabis information and news. Our roundup has everything you might have missed from the last week and more.
New Research Showing Cannabinoids May Treat Symptoms of Depression
Cannabis users also reported a higher quality of life, better sleep in the past month, less pain in the past month, and were more likely to demonstrate depression symptoms that were below clinical concern. Levels of anxiety did not differ between cannabis users and nonusers at baseline.
New York State Employers No Longer Allowed To Test Employees For Cannabis Use
This makes New York the first state in the country to prohibit employers from testing both current and prospective workers. In other states where marijuana is legal, there are laws that ban employers from penalizing workers who test positive, but this is the first regulation to explicitly prohibit workplace testing for cannabis altogether.
Texas Businesses Gear Up For Delta 8 Legal Battle
“DSHS posted the clarification below on our website in response to recent requests from hemp growers who said that there was confusion in the industry about what was allowed in consumable hemp products,” said Lara Anton, a DSHS spokesperson. But to retailers, the notice seemed arbitrary and unfair.
Arizona: Bank Of America Closes Federally-Approved Research Account
[Dr. Sue Sisley] speculated that publicity around Scottsdale Research Institute’s addition of psychoactive mushrooms, or psilocybin, to its research may have prompted the bank’s action but the bank provided “zero justification.”
Idaho: Curaleaf Target Of Lawsuits Over Mislabeled “CBD” Tincture
Five other lawsuits have been filed against Curaleaf by Fuller representing Oregonians who used the mislabeled drops. One was a 79-year-old man who underwent surgery after doctors were unable to determine what was causing his symptoms, Fuller said. Another was a woman in her 60s who was exhibiting stroke-like symptoms, he said.
Luxembourg To Legalize Personal Growth Of Cannabis
Under the legislation, people aged 18 and over will be able to legally grow up to four cannabis plants per household for personal use. Trade in seeds will also be permitted without any limit on the quantity or levels of Tetrahydrocannabinol (THC), the principal psychoactive constituent.
Costa Rican Congress Approves Medical Marijuana Legislation Despite Presidential Disapproval
Independent lawmaker Zoila Volio, who backed the law and called the move a milestone, said it would not open the floodgates to increased drug use in Costa Rica.
“I trust that President Alvarado has understood that and will not veto it,” said Volio. If Alvarado vetoes the law, lawmakers would need to again vote on it and approve it with a qualified majority.
NY State employers no longer allowed to test for cannabis use, Luxembourg to legalize personal cannabis growth, and Curaleaf the target of lawsuits over mislabeled cannabinoid tinctures in Idaho.
There can be a lot to keep track of when it comes to the fast-paced world of cannabis information and news. Our roundup has everything you might have missed from the last week and more.
New Research Showing Cannabinoids May Treat Symptoms of Depression
Cannabis users also reported a higher quality of life, better sleep in the past month, less pain in the past month, and were more likely to demonstrate depression symptoms that were below clinical concern. Levels of anxiety did not differ between cannabis users and nonusers at baseline.
New York State Employers No Longer Allowed To Test Employees For Cannabis Use
This makes New York the first state in the country to prohibit employers from testing both current and prospective workers. In other states where marijuana is legal, there are laws that ban employers from penalizing workers who test positive, but this is the first regulation to explicitly prohibit workplace testing for cannabis altogether.
Texas Businesses Gear Up For Delta 8 Legal Battle
“DSHS posted the clarification below on our website in response to recent requests from hemp growers who said that there was confusion in the industry about what was allowed in consumable hemp products,” said Lara Anton, a DSHS spokesperson. But to retailers, the notice seemed arbitrary and unfair.
Arizona: Bank Of America Closes Federally-Approved Research Account
[Dr. Sue Sisley] speculated that publicity around Scottsdale Research Institute’s addition of psychoactive mushrooms, or psilocybin, to its research may have prompted the bank’s action but the bank provided “zero justification.”
Idaho: Curaleaf Target Of Lawsuits Over Mislabeled “CBD” Tincture
Five other lawsuits have been filed against Curaleaf by Fuller representing Oregonians who used the mislabeled drops. One was a 79-year-old man who underwent surgery after doctors were unable to determine what was causing his symptoms, Fuller said. Another was a woman in her 60s who was exhibiting stroke-like symptoms, he said.
Luxembourg To Legalize Personal Growth Of Cannabis
Under the legislation, people aged 18 and over will be able to legally grow up to four cannabis plants per household for personal use. Trade in seeds will also be permitted without any limit on the quantity or levels of Tetrahydrocannabinol (THC), the principal psychoactive constituent.
Costa Rican Congress Approves Medical Marijuana Legislation Despite Presidential Disapproval
Independent lawmaker Zoila Volio, who backed the law and called the move a milestone, said it would not open the floodgates to increased drug use in Costa Rica.
“I trust that President Alvarado has understood that and will not veto it,” said Volio. If Alvarado vetoes the law, lawmakers would need to again vote on it and approve it with a qualified majority.
“California’s legal weed industry can’t compete with illicit market” [Editorial]
California’s cannabis market is booming nearly five years after voters legalized recreational weed. But there’s a catch: the vast majority of pot sales are still underground.